Frontlight ResearchEarly access
Trial site
Banner Health- MD Anderson Cancer Center
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Brain metastases1 trial
- Burkitt lymphoma1 trial
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Hodgkin lymphoma1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- and 3 more
- Phase
- Phase 1/22 trials
- Phase 32 trials
- Phase 11 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- AbbVie1 trial
- Ferring Pharmaceuticals1 trial
- Fidia Farmaceutici s.p.a.1 trial
- Institut de Recherches Internationales Servier1 trial
- Ipsen1 trial
- and 1 more
Running trials
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Recruiting
Active, not recruiting
Active, not recruiting
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Brain metastases1 recruiting
- Burkitt lymphoma1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Lung cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Terminated
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026